The Valley Desk

Clinical trial reportJournal of the American Heart AssociationPublished

Dosing and Safety Profile of Aficamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM

12 of 37 authors shown in byline order.

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
Journal of the American Heart Association
Published
Subject terms
Humans; Atrial Fibrillation; Cardiomyopathy, Hypertrophic; Benzylamines; Uracil; Stroke Volume; Treatment Outcome; Double-Blind Method; Ventricular Function, Left; Dose-Response Relationship, Drug; Adult; Aged
PubMed ID
39056349
PubMed Central ID
PMC11964075
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal